Amedisys (AMED) Tops Q3 EPS by 96c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amedisys Reports Third Quarter 2020 Financial Results - Updates 2020 Guidance
October 28, 2020 4:05 PM EDTBATON ROUGE, La., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2020.
Three-Month Periods Ended September 30, 2020 and 2019
Net service revenue increased $49.5Â million to $544.1Â million compared to $494.6Â million in 2019.Net income attributable to Amedisys, Inc. of $72.0Â million compared to $34.1Â million in 2019.Net income attributable to Amedisys, Inc. per diluted share of $2.16 (inclusive of $0.72 income tax benefit related to executive stock option exercise) compared to $1.03 in 2019.Adjusted Quarterly Results*
Adjusted EBITDA of $75.7Â million compared to $56.8Â million in... More